Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06207929 · ClinicalTrials.gov registry record
Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections
A clinical trial of COVID-19 and Influenza, Human, sponsored by Evidation Health.
- Completed
- Registry status
- 18,157
- Enrollment target
- 1
- Study location
NCT06207929 is a study of COVID-19 and Influenza, Human that has completed, run by Evidation Health. The registered enrollment target is 18,157 participants, below the 55,125-participant average among 203 other COVID-19 trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06207929, a study of COVID-19 and Influenza, Human, has completed, sponsored by Evidation Health.
- COMPLETED
- Registry status
- 18,157 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this decentralized, observational study is to enroll and observe adults in the contingent United States during the 2023-2024 flu season. The main study objectives are to create a dataset of paired wearable data, self-reported symptoms, and respiratory viral infection (RVI) from PCR testing during the 2023-2024 flu season and to develop algorithm that is able to accurately classify asymptomatic and symptomatic RVI and understand the algorithm's performance metrics.
Conditions Studied
Study Locations (1)
California
- Evidation Health - San Mateo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,157 participants |
| Start Date | 2024-01-21 |
| Est. Completion | 2024-08-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06207929
The ClinicalTrials.gov registry entry for NCT06207929 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18,157 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,125-participant average among 203 other COVID-19 trials with a reported enrollment target (67% lower). The listed sponsor is Evidation Health, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with COVID-19 appearing as the primary indexed condition, and to 0 interventions.
NCT06207929 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06207929 about?
NCT06207929 is a clinical study titled "Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections". The goal of this decentralized, observational study is to enroll and observe adults in the contingent United States during the 2023-2024 flu season. The main study objectives are to create a dataset of paired wearable data, self-reported symptoms, and respiratory viral infection (RVI) from PCR testi...
What is the current status of trial NCT06207929?
This trial is currently completed. The enrollment target is 18,157 participants. The study started on 2024-01-21. Estimated completion is 2024-08-07.
What conditions does trial NCT06207929 study?
This clinical trial studies the following conditions: COVID-19, Influenza, Human, Respiratory Syncytial Virus (RSV), Influenza a, Influenza B.
Who is sponsoring clinical trial NCT06207929?
This trial is sponsored by Evidation Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06207929 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.